Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
By Sabrina Valle (Reuters) -Mallinckrodt and Endo, drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced plans Thursday to join forces in a deal valued at $6.7 billion. Mallinckrodt Chief Executive Siggi Olafsson said the companies’ operations and products complement each other. With large manufacturing facilities in the U.S., he …
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger Read More »










